Evidence map›Paper›PMID 34836168›Full record

ArticleNutrients2021

Inhibition of Soluble Epoxide Hydrolase Is Protective against the Multiomic Effects of a High Glycemic Diet on Brain Microvascular Inflammation and Cognitive Dysfunction.

Saivageethi Nuthikattu, Dragan Milenkovic, Jennifer E Norman, John Rutledge, Amparo Villablanca

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. HowJournal of clinical and translational science · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Saivageethi NuthikattuDivision of Cardiovascular Medicine, University of California, Davis, CA 95616, USA.ORCID 0000-0002-3007-6335
Dragan MilenkovicDivision of Cardiovascular Medicine, University of California, Davis, CA 95616, USA.ORCID 0000-0001-6353-0912
Jennifer E NormanDivision of Cardiovascular Medicine, University of California, Davis, CA 95616, USA.ORCID 0000-0002-6903-6031
John RutledgeDivision of Cardiovascular Medicine, University of California, Davis, CA 95616, USA.
Amparo VillablancaDivision of Cardiovascular Medicine, University of California, Davis, CA 95616, USA.
University of California, Davis · USUniversité Clermont Auvergne · FR

Funding

Richard A. and Nora Eccles Foundation A20-0111
6 · The paper itself

Abstract

Diet is a modifiable risk factor for cardiovascular disease (CVD) and dementia, yet relatively little is known about the effect of a high glycemic diet (HGD) on the brain's microvasculature. The objective of our study was to determine the molecular effects of an HGD on hippocampal microvessels and cognitive function and determine if a soluble epoxide hydrolase (sEH) inhibitor (sEHI), known to be vasculoprotective and anti-inflammatory, modulates these effects. Wild type male mice were fed a low glycemic diet (LGD, 12% sucrose/weight) or an HGD (34% sucrose/weight) with/without the sEHI, trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB), for 12 weeks. Brain hippocampal microvascular gene expression was assessed by microarray and data analyzed using a multi-omic approach for differential expression of protein and non-protein-coding genes, gene networks, functional pathways, and transcription factors. Global hippocampal microvascular gene expression was fundamentally different for mice fed the HGD vs. the LGD. The HGD response was characterized by differential expression of 608 genes involved in cell signaling, neurodegeneration, metabolism, and cell adhesion/inflammation/oxidation effects reversible by t-AUCB and hence sEH inhibitor correlated with protection against Alzheimer's dementia. Ours is the first study to demonstrate that high dietary glycemia contributes to brain hippocampal microvascular inflammation through sEH.

Indexed as

AnimalsBrainCognitive DysfunctionDementiaDietDisease Models, AnimalEnzyme InhibitorsEpoxide HydrolasesGene ExpressionHippocampusHyperglycemiaInflammationMaleMiceMice, Inbred C57BLMicrovesselsEnzyme InhibitorsEpoxide HydrolasesSucrosebraindementiahigh glycemic dietmalessmicrovascularmulti-omicssoluble epoxide hydrolase inhibitor

Identifiers

PMID34836168
PMCPMC8622784
OpenAlexW3207986298

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.